Supply Side East In Brief
This article was originally published in The Tan Sheet
Executive Summary
Cargill glucosamine: Regenasure non-shellfish, non-animal derived glucosamine hydrochloride will be commercially available in June after Cargill's new Eddyville, Iowa plant begins manufacturing product, company says at Supply Side East in Secaucus, N.J. May 6. Cargill has dedicated $10 mil.-$15 mil. to production of the premium-priced ingredient, according to the firm. Initial trade ad for Regenasure broke in April issue of Nutraceuticals World. Ingredient is expected to be available to consumers through both pill/capsule and beverage form by the end of 2003...
|
Cargill glucosamine: Regenasure non-shellfish, non-animal derived glucosamine hydrochloride will be commercially available in June after Cargill's new Eddyville, Iowa plant begins manufacturing product, company says at Supply Side East in Secaucus, N.J. May 6. Cargill has dedicated $10 mil.-$15 mil. to production of the premium-priced ingredient, according to the firm. Initial trade ad for Regenasure broke in April issue of Nutraceuticals World. Ingredient is expected to be available to consumers through both pill/capsule and beverage form by the end of 2003.... Nutrition 21: Purchase, N.Y.-based company begins limited roll-out of Diachrome chromium picolinate/biotin supplement for improved blood sugar metabolism with launch of a 1 Web site during the week of May 5. Diachrome is available in 60-capsule quantities for $34.95 and carries claims: "Keeps your blood sugar levels in balance - that means you feel better, you have more energy" and "offers a cost-effective nutritional complement to traditional prescription drugs." Nutrition 21 says expansion to retail distribution likely will begin in early 2004, with the conclusion of a 600-patient study on the product being conducted by San Antonio, Texas healthcare company Diabetex (2 (Also see "Nutrition 21 Diachrome, Zeramax Sales To Be Backed By Research Initiatives" - Pink Sheet, 6 Jan, 2003.), p. 13).... Zeramax study : First of two research initiatives underway in cooperation with Comprehensive NeuroScience on chromium picolinate supplement scheduled for completion by mid-2003, Nutrition 21 says. The second study is expected to wind up by early 2004. Both studies examine Zeramax's ability to support individuals with atypical depression.... Daiichi Fine Chemicals: U.S. supplier funding one-year, double-blind, placebo-controlled, crossover study of Pantesin pantethine for treatment of hyperlipidemia and other chronic blood lipid disorders at the University of Minnesota. The study will involve 45 subjects and examine effect of 600 mg to 900 mg of Pantesin per day on HDL, trigylceride and other blood lipid parameters, Daiichi says. The company expects to have results by December. Pantesin is marketed in supplements under the Kal , Jarrow Formulas , Now and Carlson brands, among others, according to Daiichi.... McNeil pushing Splenda: McNeil Nutritionals focusing 2003 promotional efforts on reinforcing Splenda's lead in the low-calorie sweetener category (as defined by Chicago-based tracking firm Information Resources, Inc.), firm says. TV advertising, including one brand-building commercial showing consumers enjoying a diverse array of products containing the ingredient, is slated to break in the coming months, McNeil notes, adding the company also plans an outreach program to healthcare professionals. Johnson & Johnson highlighted McNeil Nutritionals' ability to promote strong growth for Splenda in a first quarter Jan. 21 financials release (3 'The Tan Sheet' Jan. 27, 2003, In Brief).... Pycnogenol GRAS status: Branded French maritime pine bark extract affirmed as generally recognized as safe for applications in various foods and beverages, Natural Health Sciences announces. Touted for its antioxidant capabilities, Pycnogenol currently is being studied by Frank Schonlau, PhD, Horphag Research, for its ability to assist patients with diabetes retinopathy by helping to seal leaky capillaries in the eye, Hillside, N.J.-based firm reports. Branded ingredient currently is available in several supplement products; Twinlab recently launched a Dia-Balance supplement for eye health that contains Pycnogenol. The product is aimed at diabetics and pre-diabetics.... Roche: Firm promotes recently-introduced Mixed Tocopherols 95 and ROPUFA at Supply Side East. Mixed Tocopherols 95 boasts highest level of pure tocopherol, gamma-delta content available on market today, Roche maintains. ROPUFA is said to provide "more eicossapenaenoic acid and docosapentaenoic acid per serving than other omega-3 ingredients," allowing inclusion of more polyunsaturated fatty acid in smaller supplement capsules.... St. John's wort daily dosing: Madaus AG subsidiary Euromed USA announces U.S. availability of UltraFlow St. John's wort extract, which enables production of tablets and capsules that can be dosed only once per day as opposed to the usual three times a day dosing regimen, according to the firm. In support of the product's effectiveness, Euromed cites 11,000-patient study by Hans-Peter Volz, University of Jena, Germany, published in the April issue of European pharmaceutical journal Deutsche Apoteker Zeitung. Study concludes daily administration of 600 mg UltraFlow St. John's wort "resulted in significant improvement in depressive symptoms with minimal side effects." More than 80% of physicians participating in study also noted "significantly improved compliance" with daily dosing. German supplement manufacturer Steigerwald funded the study, which used the firm's Laif 600 mg St. John's wort tablet.... |